vaccine adjuvant for vaccines that allow what today can
parenterally, i.e. injections that may be administered or
launch a production of vaccines. We donated the use of
government for mass vaccination campaigns. This prod
development,” explains Dr. Pacheco.
This is a year of celebration for Cristália on many f
40
years, we are self stocked with about 40 percent of I
40
th worldwide patent approved. In terms of medicatio
than the USP has in the U.S.,” reveals Dr. Pacheco.
br
bra
Visite:
Cristália Produtos Químicos
e Farmacêuticos Ltda.
Product
Dr Pacheco, Presidente do Cristália
